Serum xanthine oxidase in bladder carcinoma.
This study comprises of 48 normal men as control group and 49 patients with various stages of bladder carcinoma. Serum xanthine oxidase and uric acid levels were determined. Assessment in terms of changes of the enzyme xanthine oxidase was carried out prior and after surgery as a short-term follow-up. There was a significant fall of serum xanthine oxidase in patients with bladder carcinoma; it also varied with the stage of cancer.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D014527:Uric Acid / Q000097:blood; D001749:Urinary Bladder Neoplasms / Q000201:enzymology*; D014969:Xanthine Oxidase / Q000097:blood*
D014527:Uric Acid; D014969:Xanthine Oxidase